Literature DB >> 21668632

Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation?

A Cucchetti1, M Cescon, V Bertuzzo, E Bigonzi, G Ercolani, M C Morelli, M Ravaioli, A D Pinna.   

Abstract

In the last US national conference on liver transplantation for hepatocellular carcinoma (HCC), a continuous priority score, that incorporates model for end-stage liver disease (MELD), alpha-fetoprotein and tumor size, was recommended to ensure a more equitable liver allocation. However, prioritizing highest alpha-fetoprotein levels or largest tumors may select lesions at a higher risk for recurrence; similarly, patients with higher degree of liver failure could have lower postoperative survival. Data from 300 adult HCC recipients were reviewed and the proposed HCC-MELD equation was applied to verify if it can predict post-transplantation survival. The 5-year survival and recurrence rates after transplantation were 72.8 and 13.5%, respectively. Cox regression analysis confirmed HCC-MELD as predictive of both postoperative survival and recurrence (p < 0.001). The 5-year predicted survival and recurrence rates were plotted against the HCC-MELD-based dropout probability: the higher the dropout probability while on waiting list, the lower the predicted survival after transplantation, that is worsened by hepatitis C positivity; similarly, the higher the predicted HCC recurrence rate after transplantation. The HCC priority score could predict the postoperative survival of HCC recipients and could be useful in selecting patients with greater possibilities of survival, resulting in higher post-transplantation survival rates of HCC populations. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21668632     DOI: 10.1111/j.1600-6143.2011.03570.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  13 in total

1.  Liver transplantation: Toward a unified allocation system.

Authors:  Ali Zarrinpar; Ronald W Busuttil
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-05       Impact factor: 46.802

Review 2.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

Review 3.  Transplant benefit for patients with hepatocellular carcinoma.

Authors:  Alessandro Vitale; Michael Volk; Umberto Cillo
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 4.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

Review 5.  Surgery and Hepatocellular Carcinoma.

Authors:  Nobuhisa Akamatsu; Umberto Cillo; Alessandro Cucchetti; Matteo Donadon; Antonio Daniele Pinna; Guido Torzilli; Norihiro Kokudo
Journal:  Liver Cancer       Date:  2016-11-29       Impact factor: 11.740

6.  Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.

Authors:  Neil Mehta; Jennifer L Dodge; Ryutaro Hirose; John P Roberts; Francis Y Yao
Journal:  Am J Transplant       Date:  2019-04-05       Impact factor: 8.086

7.  Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.

Authors:  Neil Mehta; Jennifer L Dodge; Aparna Goel; John Paul Roberts; Ryutaro Hirose; Francis Y Yao
Journal:  Liver Transpl       Date:  2013-12       Impact factor: 5.799

8.  Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list.

Authors:  Neil Mehta; Jennifer L Dodge; John Paul Roberts; Ryutaro Hirose; Francis Y Yao
Journal:  Liver Transpl       Date:  2014-03-26       Impact factor: 5.799

Review 9.  Liver transplantation: past, present and future.

Authors:  Ali Zarrinpar; Ronald W Busuttil
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-11       Impact factor: 46.802

10.  A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.

Authors:  Neil Mehta; Jennifer L Dodge; John P Roberts; Francis Y Yao
Journal:  J Hepatol       Date:  2020-11-11       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.